# Norepinephrine

## Norepinephrine inj 4mg/4mL

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ILEV2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Indications        | Restoration of BP in acute hypotensive states. Adjunct in the treatment of cardiac arrest & profound hypotension.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Must be diluted in dextrose containing solutions prior to infusion. Add 4 mL amp to 1000 mL of 5% dextrose solution to final concentration of 4 mcg/mL Norepinephrine. IV infusion， Adult: 8-12 mcg/minute initially， adjust the rate of flow to establish and maintain a low normal blood pressure (usually 80 mm Hg to 100 mm Hg systolic) sufficient to maintain the circulation to vital organs. The average maintenance dose ranges from 2-4 mcg/minute. High dosage: Individual variation occurs in the dose required to attain and maintain an adequate blood pressure. Occasionally much larger or even enormous daily doses (as high as 68 mg) may be necessary if the patient remains hypotensive， but occult blood volume depletion should always be suspected and corrected when present. Central venous pressure monitoring is usually helpful in detecting and treating this situation. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Patients who are hypotensive from blood vol deficits except as emergency measure until blood vol therapy can be completed. Cyclopropane & halothane anesth， mesenteric or peripheral vascular thrombosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Occasionally， bradycardia; anxiety， transient headache. Plasma vol depletion (prolonged administration). Respiratory difficulty， ischemic injury.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Pregnancy          | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

